142 related articles for article (PubMed ID: 37658360)
1. Timing of surgery in patients with synchronous colorectal cancer liver metastases undergoing neoadjuvant chemotherapy: a propensity score analysis.
Wang Y; Wen N; Xiong X; Lu J; Li B; Cheng N
World J Surg Oncol; 2023 Sep; 21(1):276. PubMed ID: 37658360
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
[No Abstract] [Full Text] [Related]
3. Prognostic impact of neoadjuvant chemotherapy in patients with synchronous colorectal liver metastasis: A propensity score matching comparative study.
Ueno M; Komeda K; Kosaka H; Nakai T; Nomi T; Iida H; Tanaka S; Ikoma H; Matsuda K; Hirokawa F; Matsumoto M; Hokuto D; Mori H; Morimura R; Kaibori M; Yamaue H; Kubo S
Int J Surg; 2021 Oct; 94():106106. PubMed ID: 34536602
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy versus upfront surgery as the initial treatment for patients with resectable, synchronous colorectal cancer liver metastases.
Lee JM; Han YD; Cho MS; Hur H; Lee KY; Kim NK; Min BS
J Surg Oncol; 2023 Sep; 128(4):549-559. PubMed ID: 37288777
[TBL] [Abstract][Full Text] [Related]
5. Impact of Neoadjuvant Chemotherapy on the Postoperative Outcomes of Patients Undergoing Liver Resection for Colorectal Liver Metastases: A Population-Based Propensity-Matched Analysis.
Wiseman JT; Guzman-Pruneda F; Xourafas D; Chun YS; Ejaz A; Tsung A; Pawlik TM; Cloyd JM
J Am Coll Surg; 2019 Jul; 229(1):69-77.e2. PubMed ID: 30905856
[TBL] [Abstract][Full Text] [Related]
6. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
7. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study.
Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
J Gastrointest Surg; 2022 Apr; 26(4):772-781. PubMed ID: 34664190
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
[No Abstract] [Full Text] [Related]
9. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study.
Chen Q; Zhang R; Xing B; Li C; Xiu D; Chen J; Deng Y; Chen X; Guo R; Chen F; Peng J; Sun T; Wang H; Li M; Zheng Q; Bi X; Zhao J; Zhou J; Li Z; Huang Z; Zhang Y; Zhang Y; Cai J; Zhao H
Int J Surg; 2022 Oct; 106():106952. PubMed ID: 36220519
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
[TBL] [Abstract][Full Text] [Related]
11. Oncological outcomes of neoadjuvant chemotherapy in patients with resectable synchronous colorectal liver metastasis: A result from a propensity score matching study.
Jiang YJ; Zhou SC; Chen JH; Liang JW
Front Oncol; 2022; 12():951540. PubMed ID: 36330479
[TBL] [Abstract][Full Text] [Related]
12. Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis.
Sugimoto K; Sakamoto K; Ii Y; Amemiya K; Sugo H; Ito T; Munakata S; Takahashi M; Kojima Y; Tomiki Y; Sato K; Saiura A; Kawasaki S
BMC Surg; 2021 Apr; 21(1):188. PubMed ID: 33836701
[TBL] [Abstract][Full Text] [Related]
13. 2-4 weeks is the optimal time to operate on colorectal liver metastasis after neoadjuvant chemotherapy.
Huang Y; Jiang H; Xu L; Wu X; Wu J; Zhang Y
Biosci Trends; 2023 May; 17(2):160-167. PubMed ID: 37088556
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Outcomes of Perioperative Versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases: An International Multicentre Propensity-Score Matched Analysis with Stratification by Contemporary Risk-Scoring.
Di Martino M; Primavesi F; Syn N; Dorcaratto D; de la Hoz Rodríguez Á; Dupré A; Piardi T; Rhaiem R; Blanco Fernández G; de Armas Conde N; Rodríguez Sanjuán JC; Fernández Santiago R; Fernández-Moreno MC; Ferret G; López Ben S; Suárez Muñoz MÁ; Perez-Alonso AJ; Koh YX; Jones R; Martín-Pérez E
Ann Surg Oncol; 2022 Oct; 29(11):6829-6842. PubMed ID: 35849284
[TBL] [Abstract][Full Text] [Related]
15. Liver resection for colorectal liver-limited metastases in elderly patients: a propensity score matching analysis.
Jin KM; Wang K; Bao Q; Wang HW; Xing BC
World J Surg Oncol; 2020 Oct; 18(1):275. PubMed ID: 33099304
[TBL] [Abstract][Full Text] [Related]
16. Changes in serum lactate dehydrogenase levels as markers of pathological response and prognosis in colorectal liver metastases patients receiving neoadjuvant chemotherapy followed by resection.
Chen J; Chen Q; Yao J; Jiang Y; Zhou J; Zhao H; Cai J
Ann Palliat Med; 2021 Oct; 10(10):10276-10292. PubMed ID: 34551571
[TBL] [Abstract][Full Text] [Related]
17. Timing of Perioperative Chemotherapy Does Not Influence Long-Term Outcome of Patients Undergoing Combined Laparoscopic Colorectal and Liver Resection in Selected Upfront Resectable Synchronous Liver Metastases.
Ratti F; Fuks D; Cipriani F; Gayet B; Aldrighetti L
World J Surg; 2019 Dec; 43(12):3110-3119. PubMed ID: 31451846
[TBL] [Abstract][Full Text] [Related]
18. Resection after preoperative chemotherapy versus synchronous liver resection of colorectal cancer liver metastases: A propensity score matching analysis.
Kim CW; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim TW; Kim JC
Medicine (Baltimore); 2017 Feb; 96(7):e6174. PubMed ID: 28207557
[TBL] [Abstract][Full Text] [Related]
19. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score.
Yonekawa Y; Uehara K; Mizuno T; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
Int J Clin Oncol; 2021 Jan; 26(1):126-134. PubMed ID: 33074351
[TBL] [Abstract][Full Text] [Related]
20. Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases.
Berardi G; De Man M; Laurent S; Smeets P; Tomassini F; Ariotti R; Hoorens A; van Dorpe J; Varin O; Geboes K; Troisi RI
Eur J Surg Oncol; 2018 Jul; 44(7):1069-1077. PubMed ID: 29615295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]